Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer

Tatsuru Ohara,Yoichi Kobayashi,Ayako Yoshida,Norihito Yoshioka,Namiko Yahagi,Haruhiro Kondo,Akiko Tozawa,Kazushige Kiguchi,Nao Suzuki

Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer

2013

Tatsuru Ohara
Yoichi Kobayashi
Ayako Yoshida
Norihito Yoshioka
Namiko Yahagi
Haruhiro Kondo
Akiko Tozawa
Kazushige Kiguchi
Nao Suzuki

Background The clinical activity of combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer was evaluated retrospectively.

Keywords:

Nedaplatin
Recurrent cervical cancer
Oncology
Irinotecan
Cervical cancer
Internal medicine
Medicine
combination chemotherapy
uterine cervical cancer
Surgical oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations